AB InBev organic profit, sales top forecasts

Anheuser-Busch InBev (BUD): Q2 normalized EPS $0.93 vs consensus of $1.03.

Revenues $10.59B vs reference base of $10.35B and consensus of $10.2B.

Organic sales +3.9% vs consensus of +3.7%.

Organic EBITDA +5.8% on a like-for-like basis to $3.895B, topping analyst estimates of $3.78B.

Normalized profit $1.5B vs $1.935B.

Profit $7.46B vs $1.94B (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs